NIZO at 13th Microbiome & Probiotics R&D and Business Collaboration Forum

From April 28-29, 2025, NIZO’s microbiology experts: Dr. Guus Kortman, Susann Bellmann and Ioana Iorga will be attending the 13th Microbiome & Probiotics R&D and Business Collaboration Forum, at The Hague Conference Centre, the Netherlands.

NIZO at 13th Microbiome & Probiotics R&D and Business Collaboration Forum

Got questions about fermented foods and their health benefits? Get them answered by our experts at the Microbiome Forum – The Hague, April 28–29!

Dr. Guus Kortman, NIZO’s Senior Scientist Microbiomics, will present insights from the Fermented Food Research Consortium, showcasing our integrated in vitro approach to health benefit screening.

About the 13th Microbiome & Probiotics R&D and Business Collaboration Forum

Event: 13th Microbiome & Probiotics R&D and Business Collaboration Forum

Date: 28 – 29 April 2025

Location: The Hague Conference Centre

The 13th Microbiome & Probiotics R&D and Business Collaboration Forum is confirmed to be held on April 28-29 2025 in The Netherlands. It will be co-located with the 7th Skin Microbiome & Cosmeceuticals Congress.

Advances in the last few years have provided a much deeper understanding of the complex and dynamic microbial communities that inhabit our bodies and impact our health. High-throughput sequencing and bioinformatics have facilitated more detailed and accurate analyses of microbial communities, revolutionizing our approach to microbiome research. We now know that the microbiome affects everything from mucosal and systemic immune function to mental health and chronic diseases.

Topics covered have included gut health and disease, as well as the stunning advances being made in understanding the gut-brain axis. Speakers report on the developments in Probiotics, Prebiotics, and Postbiotic research as well as personalized nutrition and cardiometabolic disease. Women’s health, advances in HMO & infant health, and Cancer. are also explored as well as the challenges and opportunities in translating research towards commercialization, and building the partnerships and collaborations can secure investment.